Idaho Medicaid and semaglutide
Idaho Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.
In 2025 Idaho Medicaid paid for 29,015 semaglutide prescriptions (Ozempic, Rybelsus, Wegovy), 63% of its GLP-1 prescriptions and 33rd of the 50 states and DC. It reimbursed $28.3 million before rebates, $975 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 27,663 | $26.8 million | $968 |
| Rybelsus | 728 | $716,859 | $985 |
| Wegovy | 624 | $808,522 | $1,296 |
Semaglutide in the states around Idaho
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Idaho | 19 | $39/moWellmedr | 29,015 | Medicaid Wegovy: Not covered (KFF) |
| Montana | 19 | $39/moWellmedr | 15,577 | Medicaid Wegovy: No |
| Nevada | 19 | $39/moWellmedr | 44,949 | Medicaid Wegovy: No |
| Oregon | 19 | $39/moWellmedr | 30,567 | Medicaid Wegovy: No |
| Utah | 19 | $39/moWellmedr | 10,366 | Medicaid Wegovy: Not confirmed (KFF) |
| Washington | 18 | $39/moWellmedr | 31,164 | Medicaid Wegovy: No |
| Wyoming | 19 | $39/moWellmedr | 593 | Medicaid Wegovy: No |



